Skip to main content
Caplight Logo









Essenlix Corporation

Essenlix Corporation

Private
Monmouth Junction, New JerseyHealthcare & Life Scienceshttps://www.essenlix.net/

Last Round

Series A

Aug 9, 2018

Total Funding Raised

$20M

Company Overview

Essenlix Corporation operates in Healthcare & Life Sciences and is based in Monmouth Junction, New Jersey. Its latest recorded funding round was a Series A round in August 2018.

Essenlix Corporation is a medical device company that develops point-of-care diagnostic platforms for decentralized clinical testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Essenlix Corporation Comparables

Compare Essenlix Corporation with similar companies based on industry and business-model similarity.

Essenlix Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Commure
78%
Soulbrain Holdings Co. Ltd
76%
Sight Diagnostics
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Essenlix Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 9, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Essenlix Corporation Investors

Notable investors and investment history

Essenlix Corporation investors
InvestorRounds
NPX Capital Private EquitySeries A
Quadrant ManagementSeries A

Essenlix Corporation Filings

Explore SEC and related filing metadata, where available.

Essenlix Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Essenlix Corporation's valuation, stock price, and market status.

Is Essenlix Corporation a public or private company?

Essenlix Corporation is a private company.

What is the current stock price of Essenlix Corporation?

Essenlix Corporation is a private company, so its shares have no public market price. Caplight tracks Essenlix Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Essenlix Corporation worth (valuation)?

Valuation information for Essenlix Corporation is not publicly available.

Can I buy Essenlix Corporation stock?

Essenlix Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Essenlix Corporation's last funding round?

Essenlix Corporation's most recent funding round was Series A on August 9, 2018.

Who are the main investors in Essenlix Corporation?

Key investors in Essenlix Corporation include Quadrant Management.

Will Essenlix Corporation IPO soon?

No public IPO plans have been announced for Essenlix Corporation.

How can I track Essenlix Corporation secondary market activity?

Caplight tracks bids, offers, and trades in Essenlix Corporation's shares on secondary markets.

Firmographic Details

HeadquartersMonmouth Junction, New Jersey
Employee Range1
Year Founded2013
Last FundingAug 9, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?